While scientific and policy responses have traditionally focused on isolated strategies, there is an increasing need to adopt a holistic model that integrates knowledge from physiology, endocrinology, nutrition, immunology, genetics, epigenetics, and microbiome research, alongside socio-economic and environmental factors [141]
Within this framework, absorption can be considered a metabolic control module: even when dietary composition appears adequate, altered gastrointestinal kinetics may reduce effective delivery of critical substrates, shifting metabolic constraint from nutrient intake to handling efficiency
Key Players in the GLP-1 Diabetes Treatment Drugs Market Eli Lilly Sanofi Novo Nordisk Hanmi Pharmaceutical Co Boehringer Ingelheim AstraZeneca Pfizer Inc Teva Pharmaceutical Industries Ltd GlaxoSmithKline (GSK) Ganli Pharmaceuticals Tonghua Dongbao Shanghai Renhui Biopharmaceuticals Co., Ltd
Performance Benefits Glutamine and creatine offer unique performance benefits based on how they function in the body
In 2010, Hydroxycut returned to the market with a new formula
